Pain-care D2C startup Zanskar in talks for $6M Bessemer-led funding round

Delhi NCR-based Zanskar is reportedly discussing a $6 million round led by Bessemer Venture Partners. The pain-care brand sells through its own site, Blinkit, Tata 1mg, Amazon and Flipkart, while exploring physiotherapy-led wellness-centre pilots in select metros.

— Source publishedWed, 5 Aug, 2026, 19:16 IST·First seen Wed, 5 Aug, 2026, 19:24 IST·Source Inc42 · Buzz

What happened

Delhi NCR pain-care D2C startup Zanskar is in talks to raise about $6 million led by Bessemer. It sells pain-relief products via its website, Blinkit, Tata 1mg,

Key facts

  • $6 Mn proposed funding round
  • ₹2.8 Cr seed round approximately 10 months earlier
  • Founded in 2022
  • 47% of Indians aged 45+ experience joint pain
  • 31% suffer persistent back pain
  • Healthtech projected to grow at 39% CAGR from 2025
  • Healthtech market projected to exceed $37 Bn by 2030
  • Healthtech deals fell to 54 in 2025 from 78 a year earlier

Why this matters

Zanskar’s planned omnichannel and clinic-pilot expansion could create partnership opportunities for pharmacies, marketplaces and healthcare operators seeking pain-care category depth.

What to watch

  • Formal funding announcement, final round size, valuation and participation by Bessemer or other institutional investors.
  • Hiring for retail operations, physiotherapy, clinical advisory, marketplace growth or city expansion.
  • New offline centre launches, partnership-led clinics or franchise/managed-service structures.
  • Changes in Blinkit and Tata 1mg assortment, delivery coverage, ratings, search ranking or exclusive bundles.
  • Evidence of repeat-led growth: subscriptions, recovery programs, cross-category launches or reduced promotional dependence.
  • Regulatory or advertising scrutiny of therapeutic, pain-relief or clinical efficacy claims.
  • Secure or expand preferred placements on Blinkit, Tata 1mg, Amazon and Flipkart, especially in high-intent pain-relief searches.
  • Use new capital to build clinician, physiotherapist and content-led credibility rather than relying solely on discount-driven D2C acquisition.
  • Pilot small-format physiotherapy or consultation centres in Delhi NCR and one or two additional metros before committing to a broader owned-centre rollout.
  • Develop bundles and subscriptions spanning topical pain relief, recovery, mobility and preventive wellness to raise repeat purchase rates.
  • Pursue B2B partnerships with gyms, corporate wellness programs, orthopaedic clinics and physiotherapy networks to lower acquisition costs.

Also reported by